Establishment of a Dual-Vector System for Gene Delivery Utilizing Prototype Foamy Virus
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Foamy viruses (FVs) are generally recognized as non-pathogenic, often causing asymptomatic or mild symptoms in infections. Leveraging these unique characteristics, FV vectors hold significant promise for applications in gene therapy. This study introduces a novel platform technology using a pseudo-virus with single-round infectivity. In contrast to previous vector approaches, we developed a technique employing only two vectors, pcHFV lacking Env and pCMV-Env, to introduce the desired genes into target cells. Our investigation demonstrated the efficacy of the prototype foamy virus (PFV) dual-vector system in producing viruses and delivering transgenes into host cells. To optimize viral production, we incorporated the codon-optimized Env (optEnv) gene in pCMV-Env and the Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element (WPRE) at the 3’ end of the transgene in the transfer vector. Consequently, the use of optEnv led to a significant enhancement in transgene expression in host cells. Additionally, the WPRE exhibited an enhancing effect. Furthermore, the introduced EGFP transgene was present in host cells for a month. In an effort to expand transgene capacity, we further streamlined the viral vector, anticipating the delivery of approximately 4.3 kbp of genes through our PFV dual-vector system. This study underscores the potential of PFVs as an alternative to lentiviruses or other retroviruses in the realm of gene therapy.
Abstract
Foamy viruses (FVs) are generally recognized as non-pathogenic, often causing asymptomatic or mild symptoms in infections. Leveraging these unique characteristics, FV vectors hold significant promise for applications in gene therapy. This study introduces a novel platform technology using a pseudo-virus with single-round infectivity. In contrast to previous vector approaches, we developed a technique employing only two vectors, pcHFV lacking Env and pCMV-Env, to introduce the desired genes into target cells. Our investigation demonstrated the efficacy of the prototype foamy virus (PFV) dual-vector system in producing viruses and delivering transgenes into host cells. To optimize viral production, we incorporated the codon-optimized Env (optEnv) gene in pCMV-Env and the Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element (WPRE) at the 3’ end of the transgene in the transfer vector. Consequently, the use of optEnv led to a significant enhancement in transgene expression in host cells. Additionally, the WPRE exhibited an enhancing effect. Furthermore, the introduced EGFP transgene was present in host cells for a month. In an effort to expand transgene capacity, we further streamlined the viral vector, anticipating the delivery of approximately 4.3 kbp of genes through our PFV dual-vector system. This study underscores the potential of PFVs as an alternative to lentiviruses or other retroviruses in the realm of gene therapy.
참고문헌 (27)
- Baum C, "Side effects of retroviral gene transfer into hematopoietic stem cells", Blood, 101, pp.2099~2114 (2003)
- Hidai C, "Nonviral ggne therapy for cancer : a review", Diseases, 6, pp.57~ (2018)
- Raper SE, "Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer", Mol. Genet Metab, 80, pp.148~158 (2003)
- "Virology", 2019, S0042-6822(18)30390-8~
- Lindemann D, "Foamy virus biology and its application for vector development", Viruses, 3, pp.561~585 (2011)
- Achong BG, "An unusual virus in cultures from a human nasopharyngeal carcinoma", J. Natl. Cancer Inst, 46, pp.299~307 (1971)
- Rethwilm A, "Evolution of foamy viruses : the most ancient of all retroviruses", Viruses, 5, pp.2349~2374 (2013)
- Simantirakis E, "FV vectors as alternative gene vehicles for gene transfer in HSCs", Viruses, 12, pp.332~ (2020)
- Trobridge GD, "Foamy virus vector integration sites in normal human cells", Proc. Natl. Acad. Sci. USA, 103, pp.1498~1503 (2006)
- Lesbats P, "Structural basis for spumavirus GAG tethering to chromatin", Proc. Natl. Acad. Sci. USA, 114, pp.5509~5514 (2017)
- Nowrouzi A, "Genome-wide mapping of foamy virus vector integrations into a human cell line", J. Gen. Virol, 87, pp.1339~1347 (2006)
- Hamann MV, "Efficient transient genetic manipulation in vitro and in vivo by prototype foamy virus-mediated nonviral RNA transfer", Mol. Ther, 22, pp.1460~1471 (2014)
- King AMQ, "Changes to taxonomy and the international code of virus classification and nomenclature ratified by the international committee on taxonomy of viruses(2018)", Arch. Virol, 163, pp.2601~2631 (2018)
- Ledesma-Feliciano C, "Replacement of feline foamy virus bet by feline immunodeficiency virus vif yields replicative virus with novel vaccine candidate potential", Retrovirology, 15, pp.38~ (2018)
- Hirata RK, "Transduction of hematopoietic cells by foamy virus vectors", Blood, 88, pp.3654~3661 (1996)
- Russell DW, "Foamy virus vectors", J. Virol, 70, pp.217~222 (1996)
- Vassilopoulos G, "Gene transfer into murine hematopoietic stem cells with helper-free foamy virus vectors", Blood, 98, pp.604~609 (2001)
- Nasimuzzaman M, "Cell Membrane-associated heparan sulfate is a receptor for prototype foamy virus in human, monkey, and rodent cells", Mol. Ther, 20, pp.1158~1166 (2012)
- Plochmann K, "Heparan sulfate is an attachment factor for foamy virus entry", J. Virol, 86, pp.10028~10035 (2012)
- Zufferey R, "Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors", J. Virol, 73, pp.2886~2892 (1999)
- Caprariello AV, "Foamy virus as a gene transfer vector to the central nervous system", Gene Ther, 16, pp.448~452 (2009)
- Burtner CR, "Intravenous injection of a foamy virus vector to correct canine SCID-X1", Blood, 123, pp.3578~3584 (2014)
- Sweeney NP, "Rapid and efficient stable gene transfer to mesenchymal stromal cells using a modified foamy virus vector", Mol. Ther, 24, pp.1227~1236 (2016)
- Trobridge GD, "Foamy virus vectors for gene transfer", Expert Opin. Biol. Ther, 9, pp.1427~1436 (2009)
- Trobridge GD, "Helper-free foamy virus vectors", Hum. Gene Ther, 9, pp.2517~2525 (1998)
- Kim DW, "Use of the human elongation factor 1 alpha promoter as a versatile and efficient expression system", Gene, 91, pp.217~223 (1990)
- Chittenden T, "Regulated replication of an episomal simian virus 40 origin plasmid in COS7 cells", J. Virol, 65, pp.5944~5951 (1991)